← All trials
NCT04170426
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2020
- Primary completion
- Dec 15, 2021
- Completion date
- Dec 15, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 54
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Celltex Therapeutics CorporationLead sponsor
- Root Causes MedicineOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.